We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surgery for Intravenous Leiomyomatosis (SIVL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01707862
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : October 16, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.

Condition or disease
Leiomyomatosis

Detailed Description:
All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.

Study Design

Study Type : Observational
Actual Enrollment : 6 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes
Study Start Date : March 1997
Primary Completion Date : April 2012
Study Completion Date : October 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
From March 1997 to June 2011, 6 women patients were admitted to our hospital with intravenous leiomyomatosis with intracardiac extension.
Criteria

Inclusion Criteria:

  • Age more than 18 years.
  • Tumor markers were all within normal limits.
  • Patients underwent surgical management.
  • Patients were followed-up for more than 12 months.

Exclusion Criteria:

-Tumor markers were all within abnormal limits

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01707862


Locations
China
Institute of Cardiovascular Disease
Beijing, China
Sponsors and Collaborators
Li Yang
Investigators
Principal Investigator: Genetal Hospital Beijing Military Region, First class Institute of Cardiovascular Disease
More Information

Responsible Party: Li Yang, Doctor, General Hospital of Beijing PLA Military Region
ClinicalTrials.gov Identifier: NCT01707862     History of Changes
Other Study ID Numbers: GHBeijing-20121012
First Posted: October 16, 2012    Key Record Dates
Last Update Posted: October 16, 2012
Last Verified: October 2012

Keywords provided by Li Yang, General Hospital of Beijing PLA Military Region:
Intravenous leiomyomatosis
Surgery
Smooth muscle tumor

Additional relevant MeSH terms:
Leiomyomatosis
Leiomyoma
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms